# Patient and Health Care Facility Factors Associated with Advanced Cervical Lesions in Zambia Over 13-Year Period

**Authors:** M. Asiedu-Danso, M. Kalima, F. C. Ng’uni, K. Lishimpi, D. A. Larsen, L. Zhang, Amr S. Soliman

PMC · DOI: 10.21203/rs.3.rs-7510691/v1 · Research Square · 2025-10-21

## TL;DR

This study in Zambia found that HIV-positive women and rural health facilities are more likely to have advanced cervical lesions, suggesting a need for better training and resources in these areas.

## Contribution

The study identifies patient and facility factors linked to advanced cervical lesions in Zambia, offering insights to improve screening and treatment practices.

## Key findings

- HIV-positive women not on ART are 2.09 times more likely to have complicated advanced lesions.
- Rural and lower-level facilities have higher referral rates for advanced cases.
- Treatment rates for advanced lesions increased by 53.3% after 2016 due to expanded screening facilities.

## Abstract

Zambia has one of the highest burdens of cervical cancer worldwide, driven in part by its high HIV prevalence. In response, the country adopted nurse-led “screen and treat” services. Despite these efforts, anecdotal reports from Lusaka Province suggested an increase in advanced precancerous lesions among first-time screened women. This study aimed to examine patient and health care facility-level factors associated with the diagnosis and treatment of advanced cervical precancerous lesions (cervical intraepithelial neoplasia 2 and 3 (CIN2/3)) to inform targeted improvements in screening and referral practices.

This study included a retrospective cohort of first-time cervical cancer screened women in all six districts of Lusaka Province, Zambia, from 2010 to 2022. Screening data of women aged 18 and older who underwent visual inspection with acetic acid (VIA) screening were included. Patient-level variables analyzed included age, HIV status, VIA results, and treatment plan. Facility characteristics included facility level and district. Bivariate analyses assessed associations between patient/facility characteristics and advanced cervical lesion treatment. Multivariable logistic regression estimated the adjusted odds of presenting with advanced lesions requiring referral.

A total of 6,768 women were diagnosed with advanced lesions eligible for loop electrosurgical excision procedure (LEEP) treatment. Among those, 1,476 (21.8%) received LEEP treatment, and 4,164 (61.5%) were referred due to complications. Between 2017 and 2022, 53.3% more women received treatment than between 2010 and 2016. Compared with HIV-negative women, newly diagnosed women with HIV were 2.09 times more likely to have complicated advanced lesions (p < 0.0001). Compared to rural facilities, urban facilities had 0.1 -fold lower odds of referral (p < 0.0001). Compared with third-Level hospitals, health posts had the highest odds of referrals (3.3, p < 0.0001), followed by health centers (1.7, p <0.0001).

Increases in screening facilities after 2016 led to increased rates of advanced lesion detection. HIV-positive women who were not receiving antiretroviral treatment (ART) were at increased risk of complicated lesions. Finally, lower-level, and rural facilities had higher referral rates for advanced cases. These findings highlight the need to improve provider training and treatment capacity to reduce unnecessary referrals and efficient local management of screened women at rural and lower-level facilities.

## Linked entities

- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** cervical precancerous lesions (MESH:D011230), Cervical Lesions (MESH:D002575), CIN2/3 (MESH:C537153), cervical cancer (MESH:D002583), cervical intraepithelial neoplasia 2 and 3 (MESH:D002578)
- **Chemicals:** acetic acid (MESH:D019342), VIA (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12633510/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12633510/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12633510/full.md

---
Source: https://tomesphere.com/paper/PMC12633510